The Castrate-resistant Prostate Cancer Market is estimated to be valued at US$ 9.5 Bn in 2022 and is expected to exhibit a CAGR of 8.2% over the forecast period 2023 to 2030, as highlighted in a new r
| Founded year: | Not set |
| Funding rounds: | Not set |
| Total funding amount: | Not set |